Blood and tissue biomarkers in prostate cancer: state of the art.
about
A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancerBeing more realistic about the public health impact of genomic medicine.Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancerDiagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer.Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy.Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate CancerTissue and serum mesothelin are potential markers of neoplastic progression in Barrett's associated esophageal adenocarcinomaProteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer PatientsPrognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study.Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.A new dimension of FDG-PET interpretation: assessment of tumor biology.Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkers.Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer.Diagnostic biomarkers of prostate cancer.Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy.Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml
P2860
Q28478225-916D2178-ABB8-4214-93F9-A0EE71383827Q33725581-04AF793B-587F-4C09-9DA9-84712F7498D4Q33896203-1F6C8769-E585-4577-91DD-FDA58E964B17Q34455096-4126CC24-6BB5-4F88-AF52-3316F9AD2A11Q35120213-52F11951-AD57-4315-A458-14A7556F0F1FQ35141481-16261B5B-1E30-4E70-AF0C-ADB0FC9ED991Q35735074-9AABCCCB-BAD5-4AB8-BA94-734D20FC3CB5Q35815574-E941CE19-B217-4E77-ACE9-67E63B609608Q36520462-1F52E6CD-8926-4443-BE4E-5DF093A1D867Q36930831-321AD9C2-5BE2-45ED-9139-CE50C4B01BCBQ36998629-62361C38-20A8-4AE2-9DD8-808146523B04Q37827752-9BE0C68E-9D3D-4310-B76E-A04B1CB5FF3EQ39033586-ED31E111-91B0-4B94-956B-D7EE3ECB15F9Q39966817-7BC586FF-1207-4357-980C-42D809BEA174Q40034822-95D732ED-CE4B-4BC3-B23F-5DB14A3E4187Q42479099-93676095-5711-41B3-82A0-DA40713FDA3AQ46402021-C927A64D-921D-4602-93B0-989B4AAC3BBFQ57999041-7C708033-53A5-4EC4-AAFE-1031635EE8CD
P2860
Blood and tissue biomarkers in prostate cancer: state of the art.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Blood and tissue biomarkers in prostate cancer: state of the art.
@en
Blood and tissue biomarkers in prostate cancer: state of the art.
@nl
type
label
Blood and tissue biomarkers in prostate cancer: state of the art.
@en
Blood and tissue biomarkers in prostate cancer: state of the art.
@nl
prefLabel
Blood and tissue biomarkers in prostate cancer: state of the art.
@en
Blood and tissue biomarkers in prostate cancer: state of the art.
@nl
P2093
P2860
P1476
Blood and tissue biomarkers in prostate cancer: state of the art.
@en
P2093
Elisa Capizzi
Massimo Loda
Michelangelo Fiorentino
P2860
P304
131-41, Table of Contents
P356
10.1016/J.UCL.2009.11.006
P577
2010-02-01T00:00:00Z